Treatment of hypercholesterolemia with Secholex A long-term clinical trial and comparison with cholestyramine
- 1 September 1976
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 24 (3), 407-419
- https://doi.org/10.1016/0021-9150(76)90133-7
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Secholex®, clofibrate and taurine in hyperlipidaemiaAtherosclerosis, 1974
- The Effects of Colestipol Resin and of Colestipol Plus Clofibrate on the Turnover of Plasma Cholesterol in ManJournal of Clinical Investigation, 1973
- FAMILY STUDY OF SERUM LIPIDS AND LIPOPROTEINS IN CORONARY HEART-DISEASEThe Lancet, 1973
- Lipid Lowering Drugs and HyperlipidaemiaDrugs, 1973
- Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemiaJAMA, 1972
- Cholesterol Production in ObesityCirculation, 1971
- Combined Use of Clofibrate and Cholestyramine or DEAE Sephadex in HypercholesterolaemiaBMJ, 1971
- Effects of colestipol (U-26,597A), a new bile acid sequestrant, on serum lipids in experimental animals and manAtherosclerosis, 1970
- Effect of cholestyramine on the absorption of vitamin D3 and calciumGut, 1969
- Effect of cholestyramine on the fecal excretion of intravenously administered cholesterol-4-14C and its degradation products in a hypercholesterolemic patientJournal of Clinical Investigation, 1968